Molluscum Contagiosum: Understanding This Common Viral Skin Infection in 2025

Imagine discovering small, pearl-like bumps on your child's skin that seem to multiply overnight. This scenario affects millions of families worldwide each year, as molluscum contagiosum represents one of the most common viral skin infections in children and adults alike. Despite its intimidating name, this benign condition is far more manageable than many parents initially fear.

Molluscum contagiosum is a widespread viral skin infection that creates distinctive, dome-shaped bumps with characteristic central indentations. While the condition typically resolves on its own, understanding its transmission patterns, treatment options, and prevention strategies can help individuals and families navigate this common dermatological concern with confidence.

Key Takeaways

Molluscum contagiosum affects approximately 16 million Americans annually, with children aged 2-5 years being most susceptible to infection

The condition is highly contagious and spreads through direct skin contact, contaminated objects, and potentially sexual transmission in adults

Most cases resolve naturally within 6-24 months without treatment, though medical intervention may be necessary for cosmetic concerns or preventing spread

The global treatment market is projected to reach $3.67 billion by 2033, driven by increasing prevalence and demand for effective therapies

Prevention focuses on good hygiene practices and avoiding contact with infected individuals or contaminated surfaces

What Is Molluscum Contagiosum? 🔬

Molluscum contagiosum is a benign viral skin infection caused by the molluscipoxvirus, a member of the poxvirus family containing double-stranded DNA [1]. This common dermatological condition manifests as small, raised bumps on the skin that are typically flesh-colored, pink, or white with a distinctive pearl-like appearance.

The hallmark characteristic of molluscum contagiosum lesions is their central indentation or dimple, known medically as umbilication. These bumps usually measure between 2-5 millimeters in diameter, though they can occasionally grow larger, particularly in immunocompromised individuals.

Viral Classification and Subtypes

Four distinct subtypes of the molluscum contagiosum virus have been identified:

  • MCV-1: Accounts for 98% of all cases and predominantly affects children
  • MCV-2: Primarily responsible for infections in adults and individuals with HIV
  • MCV-3 and MCV-4: Found mainly in Asian and Australian populations

Unlike many other viruses, the molluscum contagiosum virus cannot currently be cultivated in laboratory settings, which has limited research into its exact mechanisms of infection and replication [3].

Understanding the Epidemiology and Prevalence 📊

The global impact of molluscum contagiosum is substantial and continues to grow. The condition represents approximately one percent of all skin diagnoses worldwide, with prevalence rates increasing across all age demographics [1].

Global Statistics

StatisticValueGlobal cases (2010)~122 millionAnnual prevalence (per 100,000)~8,000 casesAnnual incidence (per 100,000)1,200-1,400 casesUS affected population~16 million peopleNew US cases annually~6 million

The infection occurs more frequently in warm, humid regions, where the virus thrives in moist conditions that facilitate transmission [3]. This geographic pattern explains why certain tropical and subtropical areas experience higher infection rates.

Age and Gender Distribution

Children represent the primary affected demographic, with the highest incidence occurring in those aged 1-10 years, particularly children between 2-5 years old [3][6]. Research indicates that up to 62% of American children have experienced molluscum contagiosum at some point during their childhood [5].

While the condition affects boys and girls equally during childhood, adult infections show a male predominance [1]. This gender difference in adulthood likely reflects different transmission patterns, including sexual transmission routes.

High-Risk Populations and Vulnerability Factors 🎯

Certain populations face elevated risks for molluscum contagiosum infection due to various biological, environmental, and behavioral factors.

Primary Risk Groups

Immunocompromised Individuals face the highest risk and most severe presentations:

  • People living with HIV may experience clinical prevalence rates up to 18% [3]
  • Organ transplant recipients on immunosuppressive medications
  • Individuals undergoing chemotherapy or radiation therapy
  • People with primary immunodeficiency disorders

Children in Specific Environments:

  • Daycare attendees and school-age children
  • Children participating in contact sports
  • Those living in crowded conditions or institutional settings
  • Children with atopic dermatitis or eczema

Adults with Increased Exposure:

  • Sexually active teenagers and young adults
  • Healthcare workers with frequent skin contact
  • People who share personal items regularly

Contributing Factors

Several conditions can increase susceptibility to molluscum contagiosum:

Atopic Dermatitis: This common skin condition alters the skin barrier function and local immune responses, making individuals more susceptible to viral skin infections [3].

Warm, Humid Climates: Environmental factors play a significant role in transmission rates, with higher prevalence observed in tropical and subtropical regions.

Compromised Skin Integrity: Any condition that damages the skin barrier, including cuts, scratches, or other dermatological conditions, can facilitate viral entry.

Transmission Mechanisms and Contagion Patterns 🦠

Understanding how molluscum contagiosum spreads is crucial for prevention and management strategies. The virus demonstrates remarkable efficiency in transmission through multiple pathways.

Direct Transmission Routes

Skin-to-Skin Contact represents the most common transmission method:

  • Casual contact during play, sports, or daily activities
  • Sexual contact in adolescents and adults
  • Parent-to-child transmission during caregiving activities

Autoinoculation occurs when individuals spread the virus to other parts of their own body:

  • Scratching or touching existing lesions
  • Shaving over infected areas
  • Towel drying that spreads viral particles

Indirect Transmission Pathways

Contaminated Objects (fomites) can harbor the virus for extended periods:

  • Towels, washcloths, and bedding
  • Clothing and personal items
  • Toys, especially in daycare settings
  • Sports equipment and gym facilities
  • Razors and personal grooming tools
  • Tattoo equipment (rare but documented)

Environmental Transmission through shared facilities:

  • Swimming pools and hot tubs (though not definitively proven)
  • Locker rooms and changing facilities
  • Shared bathing facilities

Incubation Period and Infectious Timeline

The incubation period typically spans 2-3 months, though it can range from one week to six months [5]. This variability means some individuals may notice symptoms quickly while others experience significant delays between exposure and symptom onset.

Important Note: Individuals remain contagious as long as visible lesions are present, which can extend for months or even years if left untreated.

Clinical Presentation and Symptom Recognition 🔍

Recognizing molluscum contagiosum lesions is essential for proper diagnosis and management. The condition presents with distinctive characteristics that help differentiate it from other skin conditions.

Characteristic Lesion Appearance

Primary Features:

  • Small, dome-shaped bumps measuring 2-5mm in diameter
  • Flesh-colored, pink, or white appearance
  • Central indentation (umbilication) - the pathognomonic sign
  • Pearl-like or waxy surface texture
  • Firm consistency when palpated

Secondary Characteristics:

  • Lesions often appear in clusters or lines
  • May develop a surrounding area of redness or inflammation
  • Can become larger (up to 15mm) in immunocompromised individuals
  • Rarely exceed 10-15 lesions in healthy children

Common Anatomical Locations

In Children:

  • Face, neck, and arms
  • Trunk and abdomen
  • Areas of skin-to-skin contact during play

In Adults:

  • Genital area and inner thighs
  • Lower abdomen
  • Areas of intimate contact

Areas Typically Spared:

  • Palms of hands
  • Soles of feet
  • Mucous membranes

Associated Symptoms

While molluscum contagiosum lesions are generally asymptomatic, some individuals may experience:

  • Mild itching or irritation around lesions
  • Tenderness when bumps are touched or irritated
  • Redness surrounding individual lesions
  • Secondary bacterial infection if lesions are scratched or traumatized

Complications and Atypical Presentations

Molluscum Dermatitis: Some patients develop an inflammatory response around lesions, characterized by:

  • Redness and swelling
  • Increased itching
  • Potential secondary bacterial infection

Giant Molluscum: Immunocompromised individuals may develop unusually large lesions exceeding 15mm in diameter.

Extensive Disease: People with compromised immune systems may present with hundreds of lesions covering large body areas.

Diagnostic Approaches and Medical Evaluation 🩺

Accurate diagnosis of molluscum contagiosum typically relies on clinical examination, though additional testing may be necessary in certain circumstances.

Clinical Diagnosis

Visual Examination remains the primary diagnostic method:

  • Recognition of characteristic umbilicated lesions
  • Assessment of lesion distribution patterns
  • Evaluation of patient age and risk factors

Experienced healthcare providers can often diagnose molluscum contagiosum based solely on the distinctive appearance of lesions. The central indentation serves as the key diagnostic feature that distinguishes these lesions from other skin conditions.

Dermoscopy

Dermatoscopic examination can provide additional diagnostic certainty:

  • Enhanced visualization of central umbilication
  • Assessment of lesion surface characteristics
  • Differentiation from similar-appearing conditions

Laboratory Confirmation

When clinical diagnosis remains uncertain, several laboratory methods can provide confirmation:

Histopathological Examination:

  • Biopsy of suspicious lesions
  • Identification of characteristic molluscum bodies
  • Exclusion of other viral or neoplastic conditions

Viral DNA Detection:

  • Polymerase chain reaction (PCR) testing
  • Direct viral identification from lesion samples
  • Useful in atypical presentations

Microscopic Examination:

  • Direct visualization of viral particles
  • Potassium hydroxide (KOH) preparation
  • Identification of characteristic cellular changes

Differential Diagnosis

Healthcare providers must distinguish molluscum contagiosum from several similar-appearing conditions:

ConditionKey Distinguishing FeaturesWartsRough surface, no central indentationSebaceous cystsLarger size, deeper locationFolliculitisAssociated with hair follicles, pustularBasal cell carcinomaIrregular borders, bleeding tendencyKeratoacanthomaRapid growth, central crater

For comprehensive evaluation and expert diagnosis, patients can consult with experienced dermatologists and specialists who specialize in viral skin conditions.

Treatment Options and Management Strategies 💊

The management of molluscum contagiosum involves careful consideration of multiple factors, including patient age, immune status, lesion location, and individual preferences. Treatment approaches range from watchful waiting to active intervention.

Watchful Waiting Approach

Conservative management represents the most common initial strategy:

  • Self-resolution occurs in 6-24 months for most patients
  • Average resolution time: 13 months if left untreated
  • No scarring when lesions resolve naturally
  • Reduced risk of treatment-related complications

This approach is particularly appropriate for:

  • Healthy children with limited lesions
  • Asymptomatic presentations
  • Lesions in non-cosmetically sensitive areas

Topical Therapies

Prescription Medications:

Imiquimod (Aldara):

  • Immune response modifier
  • Applied 3 times weekly
  • Stimulates local immune response
  • Success rates: 60-80% in clinical studies

Cantharidin (Beetle Juice):

  • Derived from blister beetles
  • Applied by healthcare providers
  • Causes controlled blistering
  • Requires multiple applications

Tretinoin (Retin-A):

  • Topical retinoid
  • Promotes skin cell turnover
  • Daily application required
  • May cause skin irritation

Over-the-Counter Options:

  • Limited effectiveness
  • Primarily supportive care
  • Focus on preventing secondary infection

In-Office Procedures

Cryotherapy (Liquid Nitrogen):

  • Freezing treatment
  • Quick procedure
  • May require multiple sessions
  • Potential for temporary pigment changes

Curettage:

  • Physical removal of lesions
  • Performed under local anesthesia
  • Immediate results
  • Risk of scarring

Laser Therapy:

  • Pulsed dye laser treatment
  • Precise targeting
  • Minimal scarring risk
  • Higher cost

For patients considering professional treatment options, specialized minor surgery centers offer comprehensive evaluation and treatment services.

Emerging Treatment Modalities

Oral Medications:

  • Cimetidine (limited evidence)
  • Zinc supplementation
  • Investigational antiviral agents

Combination Therapies:

  • Multiple treatment modalities
  • Enhanced efficacy rates
  • Customized approach based on patient factors

Treatment Considerations by Population

Children:

  • Emphasis on pain-free options
  • Consideration of psychological impact
  • Family education and support

Immunocompromised Patients:

  • More aggressive treatment approach
  • Monitoring for treatment response
  • Coordination with other medical care

Adults with Genital Lesions:

  • Rapid treatment to prevent transmission
  • Consideration of sexual health implications
  • Partner evaluation and counseling

Prevention Strategies and Risk Reduction 🛡️

Effective prevention of molluscum contagiosum requires understanding transmission mechanisms and implementing appropriate protective measures across various settings.

Personal Hygiene Measures

Daily Hygiene Practices:

  • Regular handwashing with soap and water
  • Avoid sharing personal items (towels, clothing, razors)
  • Keep skin clean and moisturized
  • Promptly treat cuts and scratches

Clothing and Fabric Management:

  • Wash clothing and bedding in hot water
  • Avoid sharing clothing or personal items
  • Use separate towels for each family member
  • Regular laundering of frequently used items

Environmental Prevention

Home Environment:

  • Regular cleaning of shared surfaces
  • Disinfection of toys and play equipment
  • Separate bathing arrangements when possible
  • Education of family members about transmission

Public Facilities:

  • Use personal towels at gyms and pools
  • Wear protective footwear in communal areas
  • Avoid sharing sports equipment when possible
  • Practice good hygiene in locker rooms

School and Daycare Settings

Institutional Policies:

  • Education of staff about molluscum contagiosum
  • Protocols for managing infected children
  • Guidelines for shared equipment and toys
  • Communication with parents about prevention

Activity Modifications:

  • Temporary restriction from swimming activities
  • Covering lesions during contact sports
  • Modified participation in certain activities
  • Regular health screenings

Sexual Health Prevention

Adult Prevention Strategies:

  • Safe sexual practices
  • Regular partner communication
  • Prompt treatment of visible lesions
  • Regular dermatological examinations

For comprehensive information about prevention strategies and frequently asked questions, patients can access detailed educational resources.

Special Populations and Considerations 👥

Different population groups require tailored approaches to molluscum contagiosum management, considering unique risk factors, treatment responses, and potential complications.

Pediatric Considerations

Infants and Toddlers:

  • Higher risk due to frequent skin contact
  • Challenges in preventing autoinoculation
  • Limited treatment options due to age
  • Emphasis on parental education

School-Age Children:

  • Social and psychological implications
  • Activity restrictions and modifications
  • Peer education and awareness
  • Coordination with school health services

Adolescents:

  • Increased risk of sexual transmission
  • Body image and self-esteem concerns
  • Need for comprehensive sexual health education
  • Confidential healthcare access

Immunocompromised Populations

HIV-Positive Individuals:

  • Higher prevalence (up to 18% clinical rates)
  • More extensive disease presentation
  • Prolonged resolution times
  • Coordination with HIV care providers

Organ Transplant Recipients:

  • Immunosuppressive medication effects
  • Increased susceptibility to infection
  • Modified treatment approaches
  • Regular monitoring requirements

Cancer Patients:

  • Chemotherapy-related immunosuppression
  • Timing of treatment around cancer therapy
  • Coordination with oncology care
  • Infection prevention protocols

Healthcare Workers

Occupational Exposure Risks:

  • Direct patient contact
  • Contaminated equipment exposure
  • Need for protective equipment
  • Regular health screenings

Prevention Protocols:

  • Universal precautions implementation
  • Proper hand hygiene techniques
  • Equipment sterilization procedures
  • Staff education and training

Pregnancy and Reproductive Health

Pregnant Women:

  • Limited treatment options during pregnancy
  • Potential for vertical transmission (rare)
  • Coordination with obstetric care
  • Postpartum treatment planning

Family Planning Considerations:

  • Treatment timing around conception
  • Partner evaluation and treatment
  • Contraceptive counseling during treatment
  • Long-term reproductive health planning

Market Trends and Healthcare Economics 💰

The molluscum contagiosum treatment landscape represents a significant and growing healthcare market, driven by increasing prevalence and demand for effective therapeutic options.

Market Size and Growth Projections

The global molluscum contagiosum treatment market demonstrates robust growth:

YearMarket ValueGrowth Rate2024$2.42 billion-2025$2.53 billion4.5%2033 (projected)$3.67 billion4.75% CAGR

Alternative market analyses project the 2025 market at $2.94 billion with a 4.8% CAGR through 2033 [4].

Market Drivers

Increasing Prevalence:

  • Rising global incidence rates
  • Enhanced diagnostic awareness
  • Improved healthcare access
  • Population growth in high-risk regions

Treatment Innovation:

  • Development of new therapeutic modalities
  • Improved safety profiles
  • Enhanced patient convenience
  • Reduced treatment duration

Healthcare Infrastructure:

  • Expanding dermatology services
  • Increased specialist availability
  • Telemedicine integration
  • Enhanced patient education

Market Segments

By Treatment Type:

  • Topical therapies (largest segment)
  • Cryotherapy procedures
  • Immune-modulating treatments
  • Surgical interventions

By Healthcare Setting:

  • Hospitals and medical centers
  • Specialized dermatology clinics
  • Primary care facilities
  • Outpatient surgery centers

By Patient Population:

  • Pediatric patients (largest segment)
  • Immunocompromised individuals
  • Adult populations
  • High-risk groups

Economic Impact

Healthcare Costs:

  • Direct medical expenses
  • Lost productivity due to activity restrictions
  • Psychological counseling needs
  • Family caregiver burden

Treatment Economics:

  • Cost-effectiveness of different approaches
  • Insurance coverage variations
  • Out-of-pocket expenses
  • Long-term economic benefits of early treatment

For patients seeking cost information, treatment cost estimators can provide valuable financial planning resources.

Market Challenges

Treatment Resistance:

  • Self-limiting nature of condition
  • Patient preference for watchful waiting
  • Limited insurance coverage for cosmetic concerns
  • Variable treatment efficacy

Regulatory Considerations:

  • FDA approval processes for new treatments
  • Off-label medication use
  • Safety monitoring requirements
  • International regulatory harmonization

Research and Future Directions 🔬

Ongoing research into molluscum contagiosum continues to advance understanding of viral mechanisms, treatment efficacy, and prevention strategies.

Current Research Focus Areas

Viral Biology and Pathogenesis:

  • Molecular mechanisms of infection
  • Host immune response patterns
  • Viral replication strategies
  • Resistance mechanisms

Treatment Development:

  • Novel antiviral agents
  • Improved topical formulations
  • Combination therapy approaches
  • Targeted immunomodulation

Epidemiological Studies:

  • Population-based prevalence studies
  • Risk factor identification
  • Transmission pattern analysis
  • Global disease burden assessment

Emerging Therapeutic Approaches

Antiviral Medications:

  • Specific molluscum contagiosum virus inhibitors
  • Broad-spectrum antiviral agents
  • Oral treatment options
  • Prophylactic applications

Immunotherapy Innovations:

  • Enhanced immune response modulators
  • Vaccine development research
  • Passive immunization strategies
  • Personalized immunotherapy

Advanced Delivery Systems:

  • Nanotechnology applications
  • Sustained-release formulations
  • Targeted drug delivery
  • Minimally invasive administration

Clinical Trial Developments

Phase II and III Studies:

  • Multiple investigational compounds
  • Combination therapy trials
  • Pediatric-specific formulations
  • Long-term safety assessments

Outcome Measures:

  • Time to lesion resolution
  • Recurrence rate reduction
  • Quality of life improvements
  • Cost-effectiveness analyses

Technology Integration

Diagnostic Advances:

  • Artificial intelligence-assisted diagnosis
  • Smartphone-based lesion monitoring
  • Telemedicine consultation platforms
  • Automated screening tools

Treatment Monitoring:

  • Digital lesion tracking
  • Patient-reported outcome measures
  • Remote monitoring capabilities
  • Treatment adherence support

Global Health Initiatives

Public Health Programs:

  • Community education campaigns
  • School-based prevention programs
  • Healthcare provider training
  • Resource allocation optimization

International Collaboration:

  • Multi-national research consortiums
  • Data sharing initiatives
  • Standardized treatment protocols
  • Global surveillance systems

For the latest research developments and clinical insights, healthcare professionals and patients can access comprehensive educational resources covering current molluscum contagiosum research.

Living with Molluscum Contagiosum: Patient Support and Resources 🤝

Managing molluscum contagiosum extends beyond medical treatment to encompass psychological support, lifestyle modifications, and community resources.

Psychological and Social Impact

Children and Families:

  • Body image concerns in school-age children
  • Social stigma and peer relationships
  • Activity restrictions and lifestyle changes
  • Family stress and caregiver burden

Adult Considerations:

  • Workplace implications
  • Intimate relationship effects
  • Self-esteem and confidence issues
  • Long-term quality of life impact

Educational Resources

Patient Education Materials:

  • Comprehensive condition information
  • Treatment option explanations
  • Prevention strategy guides
  • Frequently asked questions

Healthcare Provider Resources:

  • Clinical practice guidelines
  • Treatment algorithm recommendations
  • Patient counseling tools
  • Continuing education opportunities

Support Networks

Online Communities:

  • Patient support forums
  • Caregiver resource groups
  • Expert-moderated discussions
  • Peer experience sharing

Professional Support:

  • Dermatology specialist networks
  • Pediatric healthcare providers
  • Mental health counseling services
  • Family support services

Lifestyle Modifications

Daily Living Adjustments:

  • Clothing and fabric choices
  • Personal hygiene routines
  • Activity participation guidelines
  • Social interaction modifications

Long-term Management:

  • Regular healthcare monitoring
  • Preventive care strategies
  • Family planning considerations
  • Career and lifestyle planning

For comprehensive support and expert medical care, patients can access specialized healthcare providers who understand the unique challenges of molluscum contagiosum management.

Global Perspectives and Cultural Considerations 🌍

Molluscum contagiosum presents different challenges and management approaches across various cultural and geographic contexts worldwide.

Geographic Variations

Tropical and Subtropical Regions:

  • Higher prevalence rates due to climate
  • Increased transmission in humid conditions
  • Cultural practices affecting spread
  • Limited healthcare resource access

Developed vs. Developing Countries:

  • Healthcare infrastructure differences
  • Treatment availability variations
  • Economic factors affecting care access
  • Educational resource disparities

Cultural Factors

Traditional Medicine Approaches:

  • Alternative treatment methods
  • Cultural beliefs about viral infections
  • Integration with modern medical care
  • Community healing practices

Social and Religious Considerations:

  • Modesty concerns during examination
  • Religious perspectives on treatment
  • Community support systems
  • Cultural stigma management

Healthcare System Variations

Treatment Access:

  • Insurance coverage differences
  • Specialist availability
  • Geographic access barriers
  • Economic treatment barriers

Public Health Approaches:

  • Government prevention programs
  • School health initiatives
  • Community education efforts
  • Healthcare provider training

International Collaboration

Research Partnerships:

  • Multi-national clinical trials
  • Data sharing agreements
  • Standardized treatment protocols
  • Global surveillance networks

Resource Sharing:

  • Technology transfer programs
  • Educational material distribution
  • Healthcare provider exchange
  • Treatment accessibility initiatives

For patients seeking care across different healthcare systems, multiple clinic locations can provide consistent, high-quality care regardless of geographic location.

Conclusion and Next Steps

Molluscum contagiosum represents a significant global health challenge affecting millions of individuals annually, with particular impact on pediatric populations and immunocompromised individuals. As we advance through 2025, the condition continues to demonstrate increasing prevalence rates worldwide, driving substantial growth in the treatment market projected to reach $3.67 billion by 2033.

The comprehensive understanding of molluscum contagiosum encompasses its viral etiology, transmission mechanisms, clinical presentations, and diverse treatment options. While the condition typically resolves spontaneously within 6-24 months, the decision between watchful waiting and active intervention requires careful consideration of multiple factors including patient age, immune status, lesion location, and psychosocial impact.

Key actionable steps for individuals and families include:

Implement comprehensive prevention strategies including proper hygiene practices, avoiding shared personal items, and maintaining clean environments

Seek prompt medical evaluation for suspicious skin lesions, particularly in high-risk populations or when lesions cause significant cosmetic or functional concerns

Consider treatment options carefully by consulting with healthcare providers about the benefits and risks of various therapeutic approaches based on individual circumstances

Access reliable educational resources to stay informed about current research developments, treatment innovations, and management strategies

Develop support networks through patient communities, healthcare providers, and family resources to address the psychological and social aspects of living with molluscum contagiosum

The evolving treatment landscape offers hope for improved therapeutic options, with ongoing research focusing on novel antiviral agents, enhanced immunotherapy approaches, and advanced delivery systems. As diagnostic capabilities improve and treatment access expands globally, patients can expect more effective, convenient, and personalized care options.

For individuals seeking expert evaluation and treatment, comprehensive medical services provide access to experienced healthcare providers who specialize in viral skin conditions and minor surgical procedures. The integration of evidence-based medicine with compassionate patient care ensures optimal outcomes for all individuals affected by molluscum contagiosum.

Understanding molluscum contagiosum empowers patients, families, and healthcare providers to make informed decisions about prevention, treatment, and long-term management. As research continues to advance and treatment options expand, the future holds promise for even more effective approaches to managing this common viral skin infection.

References

[1] Global Molluscum Contagiosum Treatment Market Analysis and Projections, 2024-2033.

[2] United States Epidemiological Data on Molluscum Contagiosum Prevalence and Treatment Patterns, 2025.

[3] Clinical Virology and Pathogenesis of Molluscipoxvirus Infections: A Comprehensive Review.

[4] International Market Research on Molluscum Contagiosum Treatment Trends and Economic Impact.

[5] Pediatric Dermatology Guidelines for Molluscum Contagiosum Management and Prevention.

[6] Age-Specific Prevalence and Risk Factor Analysis in Molluscum Contagiosum Infections.

[7] Immunocompromised Populations and Molluscum Contagiosum: Clinical Considerations and Treatment Approaches.

[8] Natural History and Self-Resolution Patterns in Molluscum Contagiosum: Longitudinal Study Results.

October 20, 2025
🇨🇦 Our clinic currently provides care to patients within Canada only. We apologize for any inconvenience this may cause.